{"id":"NCT01447849","sponsor":"Texas Tech University Health Sciences Center, El Paso","briefTitle":"Lubiprostone and Mucus Secretion in Patients With Chronic Constipation","officialTitle":"The Impact of Lubiprostone on Mucus Secretion in Asymptomatic Volunteers and Patients With Chronic Constipation","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2011-08","primaryCompletion":"2012-11","completion":"2012-11","firstPosted":"2011-10-06","resultsPosted":"2013-09-23","lastUpdate":"2017-06-09"},"enrollment":40,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Constipation"],"interventions":[{"type":"DRUG","name":"lubiprostone","otherNames":["Amitiza"]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Lubiprostone 24 mcg Twice a day","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The investigators hypothesize that the symptoms of chronic constipation in some patients are developed due to diminished production and secretion of the alimentary tract mucus resulting in poor lubrication.\n\nTherefore, the investigators assume that administration of lubiprostone may restore this lubrication impairment by stimulation of mucus production and secretion within the gastrointestinal tract.","primaryOutcome":{"measure":"Change of Mucus and Mucin Secretion in Patients With Chronic Constipation and in Controls.","timeFrame":"Measured after 1 week of lubiprostone and 1 week of placebo with 1 week of washout period in between.","effectByArm":[{"arm":"Lubiprostone 24 mcg BID","deltaMin":260,"sd":29},{"arm":"Placebo","deltaMin":133,"sd":16}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":11},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":[]}}